Quebec biotech company produces vaccine for H7N9 virus
QUEBEC CITY | Biopharmaceutical company Medicago, which develops vaccines based on proprietary manufacturing technologies and virus-like particles (VLPs), says it has successfully produced a new VLP vaccine candidate for the H7N9 virus. The virus is responsible for the current influenza outbreak in China.